PROGENE study, French familial prostatic cancer genetic analysis project: recruitment and analysis;Etude PROGENE, projet français d'analyse génétique du cancer de la prostate familial: Recrutement et analyse

Progres en Urologie

Volumn 6, Issue 2, 1996, Pages 226-235

  Valeri, Antoine ^a,e   Berthon, Philippe ^a   Fournier, Georges ^b   Buzzi, Jean Claude ^a   Briollais, Laurent ^a   Meria, Paul ^a   Blanche, Hélène ^c   Bellanne Chantelot, Christine ^c   Teillac, Pierre ^a   Demenais, Florence ^a   Mangin, Philippe ^d   Cohen, Nadine ^c   Le Duc, Alain ^a   Cussenot, Olivier ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b Service d'Urologie

^c FONDATION JEAN DAUSSET CEPH   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e Hôpital Saint Louts

Author keywords

Genetic counselling; Genetics; Hereditary transmission; Prostatic cancer

Indexed keywords

ARTICLE; FEMALE; FRANCE; GENETIC LINKAGE; GENETICS; HUMAN; MALE; PEDIGREE; PROSTATE TUMOR;

FEMALE; FRANCE; HUMANS; LINKAGE (GENETICS); MALE; PEDIGREE; PROSTATIC NEOPLASMS;

EID: 0030118543     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. ANDERSON D.E., BADZIOCH M.D. Familial breast cancer risks. Effects of prostate and other cancers. Cancer, 1993, 72, 114-119.
2. ANWAR K., NAKAKUKI K., SHIRAISHI T. et al. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res., 1992, 52, 5991-5996.
3. APRIKIAN A., BAZINET M., PLANTE M. et al. Family history and the risk of prostatic carcinoma in a high risk group of urological patients. J. Urol., 1995, 154, 404-406.
4. ASHLEY D. The two «hit» and multiple «hit» theories of carcinogenesis. B.J.C., 1969, 23, 313-328.
5. BERGERHEIM U.S., KUNIMI K., COLLINS V.R. et al. Deletion mapping of chromosome-8, chromosome-10, and chromosome-16 in human prostatic carcinoma. Genes Chromosom. Cancer, 1991, 3, 215-220.
6. BERTHON P., DIMITROV T., STOWER M., CUSSENOT O., MAITLAND N.J. A microdissection approach to detect molecular markers during progression of prostate cancer. Brit. J. Cancer, 1995, in press.
7. BOOKSTEIN R., MC GROGAN D., HILSENBEEK S., SHARKEY F., ALFRED D. P53 is mutated in a subset of advanced stage prostate cancers. Cancer Res., 1993, 53, 3369-3373.
8. BOVA G.S., CARTER B.S., BUSSEMAKERS M.J.B. et al. Homozygotous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 1993, 53, 3869-3873.
9. BRESSAC B., GRAND-JOUAN S Prédispositions génétiques aux cancers. Rev. Prat., 1992, 42, 803-810.
10. BREWSTER S.F., BROWNE S., BROWN K W Somatic allelic loss at the DCC, APC, nm23-Hl and P53 tumor suppressor gene loci in human prostatic carcinoma J. Urol. 1994, 151, 1073-1077.
11. CANNON L., BISHOP D., SKOLNICK M. et al. : Genetic epidemiology of prostate cancer in the Utah Mormon Genealogy. Cancer Surveys. 1982, 1, 47-69.
12. CANNON - ALBRIGHT L.A., EELES R.A., NEUHAUSEN S., SKOLNICK M.H. Test of linkage between candidate loci and a prostate cancer susceptibility locus in a set of high risk kindreds. Proceedings of the «Basic and clinical aspects of prostate cancer Conference». Las Palmas (CA) 8-12 décembre 1994.
13. CARTER B.S , EWING CM., WARD W.S. et al . Allelic loss of chromosomes 16 q and 10 q in human prostate cancer. Proc. Natl. Acad. Sci. USA. 1990, 87, 8751-8755.
14. CARTER B.S., BEATY T.H., STEINBERG G.D. et al. Mendelian inheritance of familial prostate cancer. Proc. Natl. Acad. Sci. USA. 1992, 89, 3367-3371.
15. CARTER B.S., BOVA G.S., BEATY T.H., STEINBERG G.D., CHILDS B., ISAACS W.B., WALSH P.C. Hereditary prostate cancer: epidemiologic and clinical features. J. Urol., 1993, 150, 797-802.
16. CHI S., de VERE WHITE R., MEYERS F. et al. p53 in prostate cancer: frequent expressed transition mutations. J. Natl. Cancer Inst., 1994, 86, 926-933.
17. COHEN- HAGUENAUER O. Mise en place des consultations d'oncogénétique. (Abstract) in: Boiron M et Marty M. eds. Eurocancer 95. Paris, Londres, Rome: John Libbey Eurotext. 1995, 25.
18. COLLINS V.P., KUNIRI K., BERGERHEIM U. et al. Molecular genetics and human prostatic carcinoma. Acta oncologica. 1991, 30, 181-185.
19. DONG J., LAMB P., RINKER-SCHAEFFER C., VUKANOVIC J., ICHIKAWA T., ISAACS J., BARRETT J. KAII, a metastasis suppressor gene for prostate cancer on human chromosome lip 11.2, Science. 1995, 268, 884-886.
20. EAGLE L.R., YIN X., BROTHMAN A.R., WILLIAMS B.J., ATKIN N.B., PROCHOWNIK E.V. Mutation of the MX1 gene in prostate cancer Nature Genetics. 1995, 9, 249-255.
21. FEARON E.R., VOGELSTEIN B. A genetic model for colorectal tumorogenesis. Cell., 1990, 61, 759-767.
22. FOURNIER G., LATIL A., AMET Y., ABALAIN J.H., VOLANT A., MANGIN P., FLOCH H.H., LIDEREAU R. Gene amplification in advanced-stage human prostate cancer. Urol. Res., 1995, 22.6, 343-348.
23. GAO X., HONN K.V., GRIGNON D., SAKR W., CHEN Y.Q. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res., 1993, 53, 2723-2727.
24. GAO X , ZACHAREK A., SALKOWSKI A., GRIGNON D., SAKR W., PORTER A., HONN K.V Loss of heterozygosity of the BRCAI and other loci on chromosome 17q in human prostate cancer Cancer Res., 1995, 55, 1002-1005.
25. GRAND-JOUAN S. «Conseil génétique en cancérologie». Les cancers du colon. Path Biol., 1994, 42, 107-108.
26. HAENSZEL W., KURIHARA M. Studies of Japanese migrants: I Mortality from cancer and other diseases among Japanese in the United States. J.N.C.I., 1968, 40-43.
27. JOHNSON D.R., LYTTON B., ANDERSON K.R. et al. Allelic loss and linkage studies in prostate cancer. Am. J. Hum. Genet., 1994. 55, A61.
28. KAPLAN J.C., DELPECH M. La cartographie du génome humain. In : Biologie moléculaire et médecine. Paris, Flammarion, 1993, 234-269.
29. KNUDSON A.G. Retinoblastoma: a prototype hereditary neoplasm. Semin. Oncol., 1978, 5, 57-60.
30. LATHROP G M., LALOUEL M. Easy calculation of lod scores and genetic risks on small computers. Am. J Hum. Genet., 1984, 36, 460-465.
31. LATHROP G.M., LALOUEL M., JULIER C. et al. Strategies for multilocus linkage analysis in humans. Proc. Natl. Acad. Sci. USA. 1984, 81, 3443-3446
32. LATIL A., BARON J.C., CUSSENOT O., FOURNIER G., BOCCON-GIBOD L., LE DUC A., LIDEREAU R. Oncogene amplifications in early-stage human prostate carcinomas. Int. J. Cancer. 1994, 59, 637-638.
33. LATIL A., BARON J.C., CUSSENOT O., FOURNIER G., SOUSSI T., BOCCON-GIBOD L., LE DUC A., ROUESSE J., LIDEREAU R. Genetic alterations in localized prostate cancer: identification of a common region of deletion on chromosome arm 18q. Genes. Chromos & Cancer. 1994, 11, 119-125.
34. LATIL A., CUSSENOT O., FOURNIER G. et al. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Clin. Cancer Res., 1995. In press.
35. LOEB L. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 1991, 51, 3075-3079.
36. MC WHORTER W.P., HERNANDEZ A.D , MEIKLE A.W et al. A screening study of prostate cancer in high risk families. J. Urol., 1992, 148, 826-828.
37. MEIKLE A.W., SMITH J.A., WEST D.W. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. The Prostate, 1985, 6, 121-128
38. MORGANTI G , GIANFERRARI L, CRESSERI A. et al. Recherches clinico - statistiques et génétiques sur les néoplasies de la prostate. Acta genetica Statistica, 1956, 6, 304-305.
39. MOTTET N., COSTA P., LE PELLEC L., LOUIS J.F., NAVRATIL H. Cancer de prostate.Epidémiologie. Prog. Urol., 1995, 5, 31-37.
40. OTT J. Computer-simulation methods in human linkage analysis. Proc. Natl. Acad. Sci. USA. 1989, 86, 4175-4178.
41. PHILLIPS S., BARTON C., LEE S. et al. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br. J. Cancer, 1994, 70, 1252-1257.
42. PIENTA K.J., ESPER P.S. Risk factors of prostate cancer. Annals of Internal Medicine. 1993, 118, 793-803.
43. RICHARD F., BOTTO H. Cancer de la prostate. Editions Techniques. Encycl.Med.Chir. (Paris-France). Néphrologie-Urologie, 18-560-A-10, Cancérologie, 60-18-800-A-10, 1993, 19p.
44. SAKR W.A., MACOSKA J.A., BENSON P., GRIGNON D.J., WOLMAN S.R , PONTES J.E. CRISSMAN J.D. Allelic loss in locally metastatic, multisampled prostate cancer Cancer Res. 1994, 54, 3273-3277.
45. SKOLNICK M., BEAN L.L., DINTELMAN S.M. et al. A computerized family history data base system.Sociology and Social Research. 1979, 63, 506-523.
46. SPITZ M.R., CURRIER R.D., FUEGER J.J. et al. Familial patterns of prostate cancer: A case-control analysis. J. Urol., 1991, 146, 1305-1307.
47. STEINBERG G.D., CARTER B.S., BEATY T.H. et al. Family history and the risk of prostate cancer. The Prostate, 1990, 17, 337-347.
48. TRAPMAN J., SLEDDENS H.F., VAN DER WEIDEN M.M., DINJENS W N., KONIG J.J., SCHRODER F.H., FABER P.W., BOSMAN ET. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res., 1994, 54, 6061-6064
49. TULINIUS H. EGILSSON V. OLAFSDOTTIR H et al. Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer B M.J , 1992, 305, 855-857.
50. WEEKS D.E., OTT J , LATHROP G.M. SLINK: a general simulation program for linkage analysis. Am. J. Hum. Genet., 1990, 47, A 204 (abstr).
51. WOOLF C.M. An investigation of the familial aspects of carcinoma of the prostate. Cancer, 1960, 13, 739-744.